MIRLET7D and colitis: Given that Cox-2 inhibitors can prevent Th1-cell-mediated experimental autoimmunity (Muthian et al., 2006; Ni et al., 2007) and colitis (Paiotti et al., 2012; Zrieki et al., 2010), targeting of Cox-2 by Treg-cell-derived Let-7d may be a specific Treg-cell-mediated function to prevent lethal Th1-cell-mediated inflammation.